Sbir PH2 for THC detection in drivers
Ended Definitive Contract Awarded Last action
- Contract number
- 6913G618C100020
- Awardee
-
Vox Biomedical LLC UEI FNQYUK4GTB29
- Awarding agency
-
Immediate Office of the Secretary of Transportation
Department of Transportation
- Obligated
- $348,957
Award facts
- Contract value 100% obligated
- $348,957.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Fixed Price Level of Effort
- Place of performance
- Bedford, MA 01730, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Novation Agreement | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $348,957 |
About this award
Vox Biomedical LLC, a small business based in Bedford, Massachusetts, was awarded a $348,957 Small Business Innovation Research (SBIR) Phase II contract by the U.S. Department of Transportation to develop technology for detecting tetrahydrocannabinol (THC) in drivers through breath analysis. The award, issued August 3, 2018, was designated as a total small business set-aside with a fixed-price, level-of-effort contract structure. The original completion date of August 3, 2020 was extended to December 3, 2020 to accommodate COVID-19 related impacts. The contract's work was to be performed at Vox Biomedical's facility in Bedford, Massachusetts.
This Phase II effort builds on earlier SBIR Phase I research to advance the company's breath-based detection methodologies for roadside drug screening applications. The project aligns with the Department of Transportation's interest in developing objective, non-invasive detection methods to support highway safety initiatives. Vox Biomedical's specialized expertise in volatile organic compound analysis and portable microanalysis instrumentation positioned the company to tackle this complex analytical challenge, leveraging its existing research collaborations with academic medical centers and prior funding from the National Institutes of Health for related drug detection technologies.
Quick answers
Who was awarded contract 6913G618C100020?
6913G618C100020 was awarded to Vox Biomedical LLC by Immediate Office of the Secretary of Transportation (Department of Transportation) on August 3, 2018.
How much is contract 6913G618C100020 worth?
The government has obligated $348,957 on 6913G618C100020.
Was contract 6913G618C100020 competed?
The extent of competition for 6913G618C100020 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award